Admission Date:  [**2156-1-11**]              Discharge Date:   [**2156-1-23**]  Date of Birth:  [**2088-6-21**]             Sex:   F  Service: MEDICINE  Allergies: IV Dye, Iodine Containing Contrast Media  Attending:[**First Name3 (LF) 594**] Chief Complaint: Respiratory distress secondary to pneumonia, leading to ARDS Renal failure  Major Surgical or Invasive Procedure: 1.
Endotracheal intubation 2.
Arterial line placement 3.
Central venous line placement 4.
HD line placement 5.
Initiation of hemodialysis  History of Present Illness: Ms [**Known lastname 33858**] is a 67-year-old woman with stage IV-V CKD preparing for renal replacement therapy, hypertension, insulin-dependent DM, anemia, hypertension, and gout, who presented to [**Hospital1 **] [**Location (un) 620**] ED yesterday for nausea, vomiting, diarrhea for one week, and a cough that had worsened after an episode of emesis.
CXR showed a RML consolidation suggestive of pneumonia, and patient was given ceftriaxone and metronidazole out of concern for respiratory failure due to aspiration pneumonia.
She was also given duonebs, three doses of IV lopressor, and 250 cc IVF, followed by 60 mg IV furosemide due to CXR signs of pulmonary edema.
She was given PR aspirin, started on a heparin gtt and transferred to [**Hospital1 18**] CCU, with change of sedation from propofol to fentanyl & midazolam en route.
Antibiotics were broadened to vancomycin, levofloxacin, piperacillin/tazobactam and metronidazole.
She was given a dose of furosemide 40 mg IV at 0100.
Her ventilator settings have been on assist/control 400x16-17, with FiO2 60-80% and PEEP 12.  .
She says she has had subjective fevers and acknowledges that she was not taking antibiotics at home, but cannot recall what they were prescribed for.
Past Medical History: -Stage IV-V kidney disease with baseline creatinine 3.5 (first fistula attempt failed awaiting second evaluation for fistula) -intermittent hyperkalemia -anemia secondary to renal disease on Aranesp -known kidney stone -hypertension -gout -diabetes on insulin - diabetic neuropathy s/p L 5th toe amputation  Social History: Marital Status: Single.
No foot ulcers; s/p L 5th toe amp Neuro: increased strength, gait deferred  Pertinent Results: Labs upon admission: [**2156-1-11**] 07:25PM BLOOD WBC-21.1*# RBC-3.27* Hgb-9.6* Hct-28.9* MCV-88 MCH-29.4 MCHC-33.3 RDW-15.6* Plt Ct-223 [**2156-1-11**] 07:25PM BLOOD Neuts-75* Bands-19* Lymphs-2* Monos-3 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-1* NRBC-1* [**2156-1-11**] 07:25PM BLOOD PT-12.8* PTT-90.0* INR(PT)-1.2* [**2156-1-11**] 07:25PM BLOOD Glucose-257* UreaN-81* Creat-3.5* Na-142 K-5.1 Cl-98 HCO3-24 AnGap-25* [**2156-1-11**] 11:00PM BLOOD ALT-26 AST-55* LD(LDH)-356* AlkPhos-78 TotBili-0.2 [**2156-1-12**] 05:59AM BLOOD Lipase-9 [**2156-1-11**] 07:25PM BLOOD CK-MB-19* MB Indx-8.6* cTropnT-2.49* [**2156-1-11**] 11:00PM BLOOD CK-MB-17* cTropnT-2.73* [**2156-1-12**] 05:59AM BLOOD CK-MB-11* MB Indx-8.6* cTropnT-2.25* [**2156-1-11**] 07:25PM BLOOD Calcium-9.1 Phos-5.0* Mg-2.3 [**2156-1-13**] 03:00AM BLOOD Albumin-2.5* Calcium-7.9* Phos-4.2 Mg-1.8 [**2156-1-11**] 09:03PM BLOOD Type-ART pO2-65* pCO2-40 pH-7.44 calTCO2-28 Base XS-2 Labs prior to discharge: Micro: Date   6  Lab #  Specimen  Tests  Ordered By  All [**2156-1-11**] [**2156-1-12**] [**2156-1-13**] [**2156-1-14**] [**2156-1-17**] [**2156-1-19**]    All BLOOD CULTURE Influenza A/B by DFA Rapid Respiratory Viral Screen & Culture SPUTUM STOOL URINE    All INPATIENT [**2156-1-19**] STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL INPATIENT [**2156-1-19**] BLOOD CULTURE Blood Culture, Routine-PENDING [**2156-1-19**] BLOOD CULTURE Blood Culture, Routine-PENDING [**2156-1-17**] STOOL FECAL CULTURE-FINAL; CAMPYLOBACTER CULTURE-FINAL; CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL [**2156-1-14**] STOOL FECAL CULTURE-FINAL; CAMPYLOBACTER CULTURE-FINAL; FECAL CULTURE - R/O VIBRIO-FINAL; FECAL CULTURE - R/O YERSINIA-FINAL; FECAL CULTURE - R/O E.COLI 0157:H7-FINAL; CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL [**2156-1-14**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL [**2156-1-13**] URINE Legionella Urinary Antigen -FINAL [**2156-1-12**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL [**2156-1-12**] Influenza A/B by DFA DIRECT INFLUENZA A ANTIGEN TEST-FINAL; DIRECT INFLUENZA B ANTIGEN TEST-FINAL [**2156-1-12**] Rapid Respiratory Viral Screen & Culture Respiratory Viral Culture-FINAL; Respiratory Viral Antigen Screen-FINAL [**2156-1-12**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL [**2156-1-11**] BLOOD CULTURE Blood Culture, Routine-FINAL [**2156-1-11**] BLOOD CULTURE Blood Culture, Routine-FINAL [**2156-1-11**] URINE URINE CULTURE-FINAL [**2156-1-11**] URINE Legionella Urinary Antigen -FINAL .
ET tube, right internal jugular line, and nasogastric tube are in standard placements respectively.
Bilateral consolidations and nodular opacities compatible with multifocal pneumonia & ARDS, with aspiration being a consideration as well given the predominantly dependent distribution.
New right internal jugular hemodialysis catheter ends in the right atrium just beyond the atriocaval junction.
Brief Hospital Course: This is a 67-year-old woman  with a history of CKD stage IV-V, DM2, HTN, anemia, and gout, presenting with hypoxemic respiratory failure [**2-5**] multifocal pneumonia/ARDS, with cardiac enzyme leak c/w NSTEMI, intubated, then extubated.
Hospital course c/b worsening of her CKD requiring initiation of hemodialysis.
Finished 10 day course of vancomycin, zosyn, levaquin with resolution of her fevers and leukocytosis.
The patient was initially intubated and ventilated using ARDSnet protocol.
The ventilator was easily weaned and she was maintained on nasal cannula after extubation.
The patient was started on HD and weaned off her O2.
She tolerated tunneled line placement and three consecutive session of HD and UF.
The patient was started on Sevelemar and nephrocaps.
Her medications were renally dosed.
# HYPERLIPIDEMIA: A statin was continued.
# DM: Glargine was increased to 15 for hyperglycemia.
Patient should start ACE-I once creatinine is stable  Medications on Admission: Allopurinol 200 mg daily atenolol 25 mg twice daily Aranesp 60 mg q.
2 weeks Lasix 80 mg daily Lantus 12 units at night nifedipine extended release 90 mg daily Renagel 800 mg t.i.d.
with meals aspirin 325 mg daily iron 325 mg daily guanfacine 1 mg nightly for hypertension Lidoderm patch Zocor 20 mg nightly multivitamin  Discharge Medications: 1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Tablet, Chewable(s) 2. sevelamer carbonate 800 mg Tablet Sig: One (1) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
3. metoprolol tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
4. insulin glargine 100 unit/mL Solution Sig: Fifteen (15) units Subcutaneous at bedtime.
5. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
6. darbepoetin alfa in polysorbat 60 mcg/mL Solution Sig: Sixty (60) mcg Injection every other week.
7. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).
8. ferrous sulfate 325 mg (65 mg iron) Tablet Sig: One (1) Tablet PO once a day.
Tablet(s) 9. allopurinol 100 mg Tablet Sig: Two (2) Tablet PO once a day.
Tablet(s) 10. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day): Please continue until patient is out of bed.
Discharge Disposition: Extended Care  Facility: [**Hospital6 459**] for the Aged - MACU  Discharge Diagnosis: Pneumonia End-Stage Renal Disease, on Dialysis  Discharge Condition: Mental Status: Clear and coherent.
During the first portion of your stay, you required a breathing tube to support you, but you were able to gradually come off of the breathing support.
Several changes have been made to your medication regimen.
STOP taking Lasix (furosemide) STOP taking nifedipine STOP taking guanfacine STOP taking Zocor  START taking Metoprolol 25 mg Tablet -- one half tab 2 times a day START taking Atorvastatin 40 mg Tablet -- one tab at bedtime CHANGE Aspirin 325mg daily to 81mg daily .
You should also ask your nephrologist or primary care doctor about starting a medication called an ACE inhibitor for your blood pressure and your heart.
